WO2001016859A3 - System and method for genomic and proteomic animal disease assessment via expression profile comparison - Google Patents

System and method for genomic and proteomic animal disease assessment via expression profile comparison Download PDF

Info

Publication number
WO2001016859A3
WO2001016859A3 PCT/US2000/023474 US0023474W WO0116859A3 WO 2001016859 A3 WO2001016859 A3 WO 2001016859A3 US 0023474 W US0023474 W US 0023474W WO 0116859 A3 WO0116859 A3 WO 0116859A3
Authority
WO
WIPO (PCT)
Prior art keywords
analysis device
analysis
expression profile
device reader
sample
Prior art date
Application number
PCT/US2000/023474
Other languages
French (fr)
Other versions
WO2001016859A2 (en
Inventor
Alex Titomirov
Original Assignee
Pljvita Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pljvita Corp filed Critical Pljvita Corp
Priority to AU70775/00A priority Critical patent/AU7077500A/en
Publication of WO2001016859A2 publication Critical patent/WO2001016859A2/en
Publication of WO2001016859A3 publication Critical patent/WO2001016859A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Abstract

A system and method of genomic and proteomic animal disease assessment via expression profile comparison whereby a baseline expression profiled is created by a user by depositing a biological sample on an analysis device. The biological information is read on an analysis device reader and transmitted to an analysis center where it is stored. The user deposits subsequent biological samples, which are compared to the stored sample that is originally taken. The analysis center compares the initial expression profile with subsequent expressions profiles to determine the health of the source of the sample. The biological sample can be from animals. The analysis device reader can be a wired or wireless device connected to a personal computer which in turn is connected to the Internet. In an alternate embodiment, the analysis device reader is in a cellular type telephone for wireless transmission. In yet another embodiment, the analysis device reader is in a kiosk which dispenses analysis devices and where it can be used by anyone with a credit token. Interpreted information is then returned to the appropriate person with advice on the meaning of the interpreted results, other sources of expert assistance and counseling where necessary.
PCT/US2000/023474 1999-08-27 2000-08-25 System and method for genomic and proteomic animal disease assessment via expression profile comparison WO2001016859A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU70775/00A AU7077500A (en) 1999-08-27 2000-08-25 System and method for genomic and proteomic animal disease assessment via expression profile comparison

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US15097499P 1999-08-27 1999-08-27
US60/150,974 1999-08-27
US15879599P 1999-10-12 1999-10-12
US60/158,795 1999-10-12
US49880400A 2000-02-07 2000-02-07
US09/498,804 2000-02-07

Publications (2)

Publication Number Publication Date
WO2001016859A2 WO2001016859A2 (en) 2001-03-08
WO2001016859A3 true WO2001016859A3 (en) 2001-11-22

Family

ID=27387064

Family Applications (3)

Application Number Title Priority Date Filing Date
PCT/US2000/023446 WO2001016857A2 (en) 1999-08-27 2000-08-25 System and method for genomic and proteomic agricultural disease assessment via expression profile comparison
PCT/US2000/023447 WO2001016858A2 (en) 1999-08-27 2000-08-25 System and method for genomic and proteomic human disease assessment via expression profile comparison
PCT/US2000/023474 WO2001016859A2 (en) 1999-08-27 2000-08-25 System and method for genomic and proteomic animal disease assessment via expression profile comparison

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PCT/US2000/023446 WO2001016857A2 (en) 1999-08-27 2000-08-25 System and method for genomic and proteomic agricultural disease assessment via expression profile comparison
PCT/US2000/023447 WO2001016858A2 (en) 1999-08-27 2000-08-25 System and method for genomic and proteomic human disease assessment via expression profile comparison

Country Status (3)

Country Link
EP (1) EP1410299A2 (en)
AU (3) AU7077500A (en)
WO (3) WO2001016857A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1367201A (en) * 1999-10-01 2001-05-10 Orchid Biosciences, Inc. Method and system for providing genotype clinical information over a computer network
WO2001040896A2 (en) * 1999-12-06 2001-06-07 National Center For Genome Resources System and method for metabolic profiling
AU2001278599A1 (en) * 2000-08-10 2002-02-18 Glaxo Group Limited A global electronic medicine response profile testing network
WO2002017207A2 (en) * 2000-08-23 2002-02-28 Arexis Ab System and method of storing genetic information
WO2002025563A1 (en) * 2000-09-22 2002-03-28 Cryosite Limited System and method for management of specimens
CA2387277C (en) 2001-05-25 2015-03-03 Hitachi, Ltd. Information processing system using nucleotide sequence-related information
JP4092990B2 (en) 2002-09-06 2008-05-28 株式会社日立製作所 Biological and chemical sample inspection equipment
AU2002952696A0 (en) * 2002-11-14 2002-11-28 Genomics Research Partners Pty Ltd Status determination
AU2003901196A0 (en) * 2003-03-17 2003-04-03 Commonwealth Scientific And Industrial Research Organisation Analysis method
US20060136143A1 (en) * 2004-12-17 2006-06-22 General Electric Company Personalized genetic-based analysis of medical conditions
AP2010005108A0 (en) * 2007-06-06 2010-02-28 Tata Consultancy Services Ltd A mobile based advisory system and a method thereof
WO2012070056A2 (en) 2010-11-23 2012-05-31 Krisani Biosciences (P) Ltd Method and system for prognosis and treatment of diseases using portfolio of genes
WO2015085326A1 (en) * 2013-12-07 2015-06-11 Brandon Colby System and method for real-time personalization utilizing an individual's genomic data
CN105095623B (en) * 2014-05-13 2017-11-17 中国人民解放军总医院 Screening assays, platform, server and the system of disease biomarkers
CN111276248B (en) * 2020-01-20 2023-09-12 苏州帕诺米克生物医药科技有限公司 State determination system and electronic device

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5704366A (en) * 1994-05-23 1998-01-06 Enact Health Management Systems System for monitoring and reporting medical measurements
WO1998024212A1 (en) * 1996-11-29 1998-06-04 Micromedical Industries Limited Telemedicine system
US5827180A (en) * 1994-11-07 1998-10-27 Lifemasters Supported Selfcare Method and apparatus for a personal health network
US5878746A (en) * 1993-08-25 1999-03-09 Lemelson; Jerome H. Computerized medical diagnostic system
US5935060A (en) * 1996-07-12 1999-08-10 First Opinion Corporation Computerized medical diagnostic and treatment advice system including list based processing
WO1999042558A1 (en) * 1998-02-20 1999-08-26 Nanogen, Inc. Advanced active devices and methods for molecular biological analysis and diagnostics
WO2000051519A2 (en) * 1999-03-02 2000-09-08 Goetz Gerald E Veterinary medication monitoring system and apparatus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6055512A (en) * 1997-07-08 2000-04-25 Nortel Networks Corporation Networked personal customized information and facility services
US6014451A (en) * 1997-10-17 2000-01-11 Pioneer Hi-Bred International, Inc. Remote imaging system for plant diagnosis

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5878746A (en) * 1993-08-25 1999-03-09 Lemelson; Jerome H. Computerized medical diagnostic system
US5704366A (en) * 1994-05-23 1998-01-06 Enact Health Management Systems System for monitoring and reporting medical measurements
US5827180A (en) * 1994-11-07 1998-10-27 Lifemasters Supported Selfcare Method and apparatus for a personal health network
US5935060A (en) * 1996-07-12 1999-08-10 First Opinion Corporation Computerized medical diagnostic and treatment advice system including list based processing
WO1998024212A1 (en) * 1996-11-29 1998-06-04 Micromedical Industries Limited Telemedicine system
WO1999042558A1 (en) * 1998-02-20 1999-08-26 Nanogen, Inc. Advanced active devices and methods for molecular biological analysis and diagnostics
WO2000051519A2 (en) * 1999-03-02 2000-09-08 Goetz Gerald E Veterinary medication monitoring system and apparatus

Also Published As

Publication number Publication date
AU6939700A (en) 2001-03-26
AU7826100A (en) 2001-03-26
WO2001016857A2 (en) 2001-03-08
WO2001016858A2 (en) 2001-03-08
WO2001016857A3 (en) 2002-03-21
EP1410299A2 (en) 2004-04-21
WO2001016859A2 (en) 2001-03-08
AU7077500A (en) 2001-03-26
WO2001016858A3 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
WO2001016859A3 (en) System and method for genomic and proteomic animal disease assessment via expression profile comparison
Haubenberger et al. Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor
Aardoom et al. E-health interventions for eating disorders: emerging findings, issues, and opportunities
US20200395112A1 (en) A System and Method for Documenting a Patient Medical History
Douglas et al. Comparative validity analysis of multiple measures of violence risk in a sample of criminal offenders
Littell et al. Stages of change: A critique
Walters Risk-appraisal versus self-report in the prediction of criminal justice outcomes: A meta-analysis
Nieuwenhuis et al. The six spot step test: a new measurement for walking ability in multiple sclerosis
Besson et al. The speed of visual recognition memory
Pelissier Gender differences in substance use treatment entry and retention among prisoners with substance use histories
WO2001063544A3 (en) Health data collection and management system
Ottenbacher et al. Comparison of logistic regression and neural network analysis applied to predicting living setting after hip fracture
Wang et al. Integrating TTF and IDT to evaluate user intention of big data analytics in mobile cloud healthcare system
IL155342A0 (en) Devices and methods for accessing and analyzing physiological fluid
US10152702B2 (en) Apparatus and methods for analyzing a medical condition
Grosholz et al. Assessing the relationship between physical health and inmate misconduct
Latham et al. The role of neighborhood safety in recovery from mobility limitations: Findings from a national sample of older Americans (1996–2008)
CN105528611A (en) Ache identification classifier training method and device
Eckman et al. Using handgrip strength to screen for diabetes in developing countries
Beaver et al. Social support or biosocial support? A genetically informative analysis of social support and its relation to self-control
Mun et al. An SEM approach for the evaluation of intervention effects using pre-post-post designs
Pavlova et al. Impact of tactile sensation on dexterity: a Cross-Sectional Study of Patients with impaired hand function after stroke
US20080319784A1 (en) Online health consultation
Little et al. Relationship of DUI recidivism to moral reasoning, sensation seeking, and MacAndrew alcoholism scores
Graves et al. Biosensors to monitor MS activity

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP